亚虹医药-U
(688176)
| 流通市值：25.42亿 | | | 总市值：38.30亿 |
| 流通股本：3.78亿 | | | 总股本：5.70亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 473,364,827.48 | 1,168,116,655.42 | 2,105,888,987.91 | 1,738,214,569.8 |
| 应收票据及应收账款 | 43,111,819.61 | 31,743,068.86 | 20,223,327.19 | 8,675,293.86 |
| 应收账款 | 43,111,819.61 | 31,743,068.86 | 20,223,327.19 | 8,675,293.86 |
| 预付款项 | 21,357,449.99 | 14,522,671.89 | 12,739,789.82 | 12,199,488.83 |
| 其他应收款合计 | 12,586,437.42 | 16,828,237.91 | 11,432,049.72 | 5,898,828.87 |
| 存货 | 2,156,763.7 | 1,890,647.08 | 2,670,816.74 | 1,612,977.31 |
| 其他流动资产 | - | - | - | 14,544,364.54 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,598,463,174.92 | 2,089,406,719.53 | 2,305,728,450.84 | 2,375,453,052.65 |
| 非流动资产: | | | | |
| 其他债权投资 | 481,774,517.12 | 120,908,115.29 | 10,349,224.88 | 10,266,950.91 |
| 其他权益工具投资 | 12,318,308.46 | 12,528,914.4 | 16,169,505 | 16,141,473.3 |
| 固定资产 | 28,033,062.56 | 29,553,236.85 | 30,914,618.48 | 31,860,890.8 |
| 使用权资产 | 57,126,018.09 | 50,933,340.2 | 52,874,982.9 | 56,637,866.61 |
| 无形资产 | 56,136,126.59 | 57,515,583.72 | 59,261,610.72 | 61,389,988.14 |
| 长期待摊费用 | 6,833,194.25 | 7,708,107.62 | 8,531,926.48 | 9,859,296.52 |
| 递延所得税资产 | 1,914,294.95 | 1,826,317.91 | 1,759,675.93 | 1,262,716.62 |
| 其他非流动资产 | 71,243,831.23 | 73,631,779.26 | 72,462,540.48 | 69,398,231.65 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 715,379,353.25 | 354,605,395.25 | 252,324,084.87 | 256,817,414.55 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,313,842,528.17 | 2,444,012,114.78 | 2,558,052,535.71 | 2,632,270,467.2 |
| 流动负债: | | | | |
| 短期借款 | 66,200,000 | 109,900,000 | 109,900,000 | 73,400,000 |
| 应付票据及应付账款 | 40,637,372.83 | 43,030,708.48 | 55,105,283.16 | 67,282,681.17 |
| 应付账款 | 40,637,372.83 | 43,030,708.48 | 55,105,283.16 | 67,282,681.17 |
| 预收款项 | - | - | 2,597.76 | - |
| 合同负债 | 2,153,989.06 | 1,939,809.44 | - | - |
| 应付职工薪酬 | 24,425,280.35 | 20,796,667.52 | 13,070,060.16 | 27,589,820.9 |
| 应交税费 | 4,886,996.06 | 4,395,829.44 | 5,117,478.18 | 1,836,938.36 |
| 其他应付款合计 | 23,870,092.58 | 16,606,370.53 | 9,430,608.58 | 4,944,168.09 |
| 一年内到期的非流动负债 | 15,716,469.01 | 9,620,199.64 | 10,542,312.81 | 10,293,538.54 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 177,890,199.89 | 206,289,585.05 | 203,168,340.65 | 185,347,147.06 |
| 非流动负债: | | | | |
| 租赁负债 | 50,477,644.38 | 47,563,516.9 | 48,437,409.25 | 50,765,127.2 |
| 递延收益 | 5,823,490 | 6,015,476.46 | 6,205,057.15 | 6,389,460.85 |
| 递延所得税负债 | 2,237 | - | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 56,303,371.38 | 53,578,993.36 | 54,642,466.4 | 57,154,588.05 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 234,193,571.27 | 259,868,578.41 | 257,810,807.05 | 242,501,735.11 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 570,000,000 | 570,000,000 | 570,000,000 | 570,000,000 |
| 资本公积 | 2,874,307,329.49 | 2,868,692,461.63 | 2,865,723,752.26 | 2,863,052,095.07 |
| 减:库存股 | 47,825,960.06 | 23,001,886.26 | 8,142,147.87 | - |
| 其他综合收益 | -2,605,505.37 | -4,329,361.12 | -1,444,626.02 | -375,225.89 |
| 未分配利润 | -1,315,547,450.98 | -1,228,697,282.25 | -1,127,555,595.38 | -1,044,707,387.52 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,078,328,413.08 | 2,182,663,932 | 2,298,581,382.99 | 2,387,969,481.66 |
| 少数股东权益 | 1,320,543.82 | 1,479,604.37 | 1,660,345.67 | 1,799,250.43 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,079,648,956.9 | 2,184,143,536.37 | 2,300,241,728.66 | 2,389,768,732.09 |
| 负债和股东权益合计 | 2,313,842,528.17 | 2,444,012,114.78 | 2,558,052,535.71 | 2,632,270,467.2 |
| 公告日期 | 2024-10-30 | 2024-08-29 | 2024-04-30 | 2024-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |